Leidos stock trades steady as recent earnings and defense backlog shape investor view

Leidos Holdings Inc. (ISIN US5253271028) stock continues to reflect the group’s position as a major US defense and technology contractor, with recent reported figures showing steady revenue growth and a sizeable contract backlog that underpins future activity. In its most recently reported full fiscal year 2025, Leidos disclosed revenue of approximately $16.4 billion, highlighting its scale within the government services and defense technology market. The company has also emphasized that a multi-billion dollar backlog of signed contracts provides visibility into future workloads and cash flows, which is a core element of how investors assess Leidos stock as part of the wider defense and technology sector.

Revenue near $16.4 billion

In its fiscal 2025 reporting, Leidos stated that full-year revenue reached about $16.4 billion, representing an increase versus the prior fiscal year when revenue had been closer to $15.4 billion. This comparison suggests year-over-year top line growth of roughly $1.0 billion, or about 6.5%, which investors often read as an indicator of continued demand for its portfolio of defense, intelligence, civil, and health-related solutions. The company has historically reported its revenue across multiple operating segments, such as Defense Solutions, Civil, and Health, each contributing a different mix of long-term contracts, project-based work, and recurring support services.

Leidos also reported that operating income and net income rose alongside revenue in fiscal 2025, supported by contract execution and cost management. For example, the company indicated that net income attributable to Leidos shareholders for the year was around $940 million, up from roughly $820 million in the prior fiscal year, implying growth of approximately 14.6%. That improvement in profitability, combined with steady revenue gains, is often interpreted by investors as a sign that Leidos is not only expanding its business but also improving how efficiently it converts revenue into earnings.

Backlog above $35 billion

The contract backlog reported by Leidos is a central metric for understanding the trajectory of Leidos stock, because it represents work that has been awarded but not yet fully performed. In its latest annual disclosures, Leidos highlighted a total backlog of more than $35 billion, up from about $33 billion a year earlier. This increase of roughly $2 billion suggests that new contract awards exceeded the value of work completed, thereby increasing the pool of future revenue. In practical terms, this backlog includes multi-year defense and government contracts, technical services agreements, and project-based engagements, many of which involve mission-critical systems for US federal agencies and allied governments.

Leidos has also emphasized book-to-bill ratios in its reporting, which compare new contract awards to revenue recognized over a given period. A book-to-bill ratio above 1.0 in fiscal 2025 indicates that the company signed more new business than it burned through in existing contracts, a pattern that investors typically view as supportive of long-term revenue stability. For Leidos, this demand is often tied to ongoing modernization of defense systems, cybersecurity and intelligence requirements, and complex infrastructure and health technology projects, all areas where its engineering and integration capabilities are central.

Cash flow and margin dynamics

Cash generation remains a key factor for Leidos stock, especially in a sector where large contracts and milestone payments can create timing differences between reported earnings and cash receipts. In its most recent fiscal year, Leidos reported operating cash flow of roughly $1.5 billion, compared with approximately $1.3 billion in the prior year, reflecting an increase of about $200 million. This improvement in cash flow provides the company with flexibility to fund capital expenditures, service debt, and return capital to shareholders through dividends and share repurchases when appropriate.

Margins are another important metric in analyzing Leidos. The company’s fiscal 2025 operating margin was reported at around 9%, modestly higher than the roughly 8.5% achieved in the prior year. This upward move, while incremental, indicates that Leidos has been able to manage labor costs, subcontractor expenses, and overhead while executing complex contracts. For many defense and services companies, margin improvements can be challenging because contracts are often fixed-price or cost-plus with tight profit parameters; a small margin increase is therefore a meaningful signal for investors about discipline in bidding and execution.

Defense solutions and critical systems

Beyond headline financials, the operational profile of Leidos provides context for the numbers that underpin Leidos stock. The company’s Defense Solutions segment works on command-and-control systems, logistics, surveillance and reconnaissance, and other mission-critical capabilities. These programs often run for many years and are funded through US Department of Defense and allied government budgets. The combination of long-term contracts and periodic modernization cycles drives steady revenue but also requires Leidos to invest in research, development, and technical talent to remain competitive.

Leidos also participates in intelligence and cybersecurity projects, where it helps agencies process large volumes of data, secure networks, and build analytical tools. While revenue contributions from these areas are dispersed across multiple contracts, they collectively support Leidos’ growth at a time when digital threats and data requirements are expanding. This mix of traditional defense hardware integration and cutting-edge software and analytics work can offer investors a diversified exposure to both legacy and emerging defense technologies.

Civil and health market exposure

The Civil segment of Leidos includes work on transportation systems, energy infrastructure, environmental services, and digital modernization for civilian agencies. These contracts can provide a counterbalance to defense spending cycles, as infrastructure and civil projects often follow separate budget paths. Revenue from civil programs can therefore help smooth overall company performance when defense budgets fluctuate.

Leidos’ Health segment has focused on information technology and services for healthcare providers and government health agencies, including electronic health record implementation, data analytics, and support services. While smaller than the defense-focused segments, health-related business contributes to overall revenue and offers exposure to long-term trends in healthcare digitization and data security. In aggregate, this segment mix means that Leidos stock is not purely a defense play but rather a broader government and critical infrastructure services investment.

Leidos technology and product focus

Leidos delivers a range of technology solutions rather than a single consumer product. Its offerings include integrated mission systems, software platforms for data analysis, engineering services, and security technologies. In aviation security, for example, Leidos supplies scanning and detection technologies that help airports and transport hubs manage safety and throughput. In cyber and intelligence, it provides tools and services that enable clients to visualize, process, and secure complex data streams.

The company’s approach emphasizes systems integration, where it combines hardware, software, and services into cohesive solutions tailored to specific missions. For investors examining Leidos stock, this systems integrator role is important because it indicates that revenue is often tied to long-term relationships and ongoing support, rather than one-off product sales. As digital transformation and security requirements evolve, Leidos’ technology portfolio positions it to bid on new contracts that require both legacy expertise and modern solutions.

Leidos stock and market context

Leidos Holdings is listed on the New York Stock Exchange, where its stock is traded under the ticker symbol LDOS. As of a recent trading day in 2026, Leidos shares were quoted at around $115 per share, placing the company’s equity value in a range that reflects both its scale and its role in the US defense and government services sector. At that price level, the company’s market capitalization has been in the vicinity of $15 billion, indicating that equity investors assign a substantial valuation to its backlog, cash flow, and earnings profile.

The shares’ performance over the prior twelve months has broadly mirrored the interplay between defense spending expectations, broader equity market conditions, and company-specific earnings results. When Leidos reported its fiscal 2025 numbers, the combination of revenue growth near 6.5%, net income expansion of roughly 14.6%, and a backlog increase of about $2 billion contributed to a constructive narrative around the stock. For many investors, the key questions now center on how Leidos will manage margins, continue winning contracts, and allocate capital between growth initiatives and shareholder returns, all set against the backdrop of evolving defense and technology demands.